Immune cells that spot TB-infected cells point to better vaccines

Tuberculosis remains a challenge because the immune system does not always spot and eliminate Mycobacterium tuberculosis (Mtb) once it hides inside immune cells. To understand what effective immune recognition looks like, researchers led by Stephen M. Carpenter studied T cells taken from people with latent Mtb infection (LTBI). Rather than only measuring responses to isolated pieces of the bacterium, the team quantified T cell activation in response to macrophages actually infected with Mtb. This approach asks a direct question: do memory CD4+ T cells — the long-lived cells that remember past encounters — recognize infected host cells where the bacteria live? By comparing how T cells react to infected macrophages versus when they are presented with extra antigen, the researchers aimed to reveal whether the memory T cell pool in LTBI is ready to find and respond to infected cells, or whether important gaps remain. The goal is practical: to identify the kinds of T cells a future TB vaccine should produce to prevent active disease by targeting infected cells directly.

To probe the specificity and function of these T cells, the team used T cell antigen receptor (TCR) sequencing and single-cell transcriptomics. TCR sequencing showed that in stable LTBI more than >70% of unique and more than >90% of total Mtb-specific TCR clonotypes were linked to recognition of infected macrophages, a strong indication that most of the T cell repertoire can detect infected host cells. However, a subset of clonotypes required exogenous antigen exposure to become activated, suggesting incomplete recognition across the entire memory pool. The researchers also identified clonotypes that were specific for multiple Mtb antigens as well as clonotypes reactive to other pathogens, indicating a mix of Mtb-specific and non-specific activation among the cells. Single-cell transcriptomics revealed that Mtb-specific T cells express a clear set of effector functions dominated by IFNγ, TNF, IL-2, and GM-CSF, along with chemokine production and signaling pathways, defining the molecular profile of the cells most likely to control infection.

These findings carry practical implications for TB prevention and vaccine design. If most memory CD4+ T cells in LTBI can recognize infected macrophages and a core group produce IFNγ, TNF, IL-2 and GM-CSF, then vaccines that elicit such cells could be more effective at preventing disease. The observation that some clonotypes need exogenous antigen to respond warns that not all memory responses are equally useful — vaccines should aim to generate T cells that can detect antigen as it is naturally presented in infected host cells. The mix of Mtb-specific and non-specific clonotypes also suggests that measuring the right T cell functions and targets will be important when evaluating vaccines or immune responses. In short, the work argues for TB vaccines that drive T cells able to recognize infected macrophages and execute the canonical effector programs identified by single-cell transcriptomics, increasing the chance of protective immunity against tuberculosis.